188 related articles for article (PubMed ID: 8584586)
41. The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.
De Hert M; Sermon J; Geerts P; Vansteelandt K; Peuskens J; Detraux J
CNS Drugs; 2015 Aug; 29(8):637-58. PubMed ID: 26293744
[TBL] [Abstract][Full Text] [Related]
42. Management of treatment refractory schizophrenia.
Morrison DP
Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
[No Abstract] [Full Text] [Related]
43. Principles and results of family therapy in schizophrenia.
Hahlweg K; Wiedemann G
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 4():108-15. PubMed ID: 10654116
[TBL] [Abstract][Full Text] [Related]
44. Algorithm for treatment-refractory schizophrenia.
Koshino Y
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S9-13. PubMed ID: 10560891
[TBL] [Abstract][Full Text] [Related]
45. 'Psychosocial' interventions with families and their effects on the course of schizophrenia: a review.
Barrowclough C; Tarrier N
Psychol Med; 1984 Aug; 14(3):629-42. PubMed ID: 6149587
[TBL] [Abstract][Full Text] [Related]
46. A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder.
Simpson GM; Mahmoud RA; Lasser RA; Kujawa M; Bossie CA; Turkoz I; Rodriguez S; Gharabawi GM
J Clin Psychiatry; 2006 Aug; 67(8):1194-203. PubMed ID: 16965196
[TBL] [Abstract][Full Text] [Related]
47. Early intervention, time-limited, targeted pharmacotherapy of schizophrenia.
Carpenter WT; Heinrichs DW
Schizophr Bull; 1983; 9(4):533-42. PubMed ID: 6140752
[TBL] [Abstract][Full Text] [Related]
48. A program for relapse prevention in schizophrenia: a controlled study.
Herz MI; Lamberti JS; Mintz J; Scott R; O'Dell SP; McCartan L; Nix G
Arch Gen Psychiatry; 2000 Mar; 57(3):277-83. PubMed ID: 10711914
[TBL] [Abstract][Full Text] [Related]
49. Integrated treatment of schizophrenia.
Lenroot R; Bustillo JR; Lauriello J; Keith SJ
Psychiatr Serv; 2003 Nov; 54(11):1499-507. PubMed ID: 14600309
[TBL] [Abstract][Full Text] [Related]
50. Family interventions for schizophrenia.
Dixon LB; Lehman AF
Schizophr Bull; 1995; 21(4):631-43. PubMed ID: 8749890
[TBL] [Abstract][Full Text] [Related]
51. Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.
Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Jockers-Scherübl MC; Kühn KU; Lemke M; Bechdolf A; Bender S; Degner D; Schlösser R; Schmidt LG; Schmitt A; Jäger M; Buchkremer G; Falkai P; Klingberg S; Köpcke W; Maier W; Häfner H; Ohmann C; Salize HJ; Schneider F; Möller HJ;
J Clin Psychiatry; 2007 Nov; 68(11):1763-74. PubMed ID: 18052570
[TBL] [Abstract][Full Text] [Related]
52. [The long-term treatment of schizophrenia].
Herold R
Orv Hetil; 2012 Jul; 153(26):1007-12. PubMed ID: 22735371
[TBL] [Abstract][Full Text] [Related]
53. Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Lemke M; Heuser I; Maier W; Huff W; Schmitt A; Sauer H; Riedel M; Klingberg S; Köpcke W; Ohmann C; Möller HJ;
J Clin Psychiatry; 2011 Feb; 72(2):205-18. PubMed ID: 20673559
[TBL] [Abstract][Full Text] [Related]
54. Antipsychotic drug doses in a schizophrenia inpatient unit.
Galletly CA
Aust N Z J Psychiatry; 1992 Dec; 26(4):574-6. PubMed ID: 1362051
[TBL] [Abstract][Full Text] [Related]
55. [Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia].
Fujii Y
Seishin Shinkeigaku Zasshi; 2001; 103(12):1030-5. PubMed ID: 11925840
[No Abstract] [Full Text] [Related]
56. Family treatment and medication dosage reduction in schizophrenia: effects on patient social functioning, family attitudes, and burden.
Mueser KT; Sengupta A; Schooler NR; Bellack AS; Xie H; Glick ID; Keith SJ
J Consult Clin Psychol; 2001 Feb; 69(1):3-12. PubMed ID: 11302274
[TBL] [Abstract][Full Text] [Related]
57. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose method.
Yamanouchi Y; Sukegawa T; Inagaki A; Inada T; Yoshio T; Yoshimura R; Iwata N
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522380
[TBL] [Abstract][Full Text] [Related]
59. Intermittent medication--an alternative?
Gaebel W
Acta Psychiatr Scand Suppl; 1994; 382():33-8. PubMed ID: 7916527
[TBL] [Abstract][Full Text] [Related]
60. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
